3903 related articles for article (PubMed ID: 7059953)
1. Pilot studies using melanoma tumor-associated antigens (TAA) in specific-active immunochemotherapy of malignant melanoma.
Hollinshead A; Arlen M; Yonemoto R; Cohen M; Tanner K; Kundin WD; Scherrer J
Cancer; 1982 Apr; 49(7):1387-404. PubMed ID: 7059953
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
Haanen JB; Baars A; Gomez R; Weder P; Smits M; de Gruijl TD; von Blomberg BM; Bloemena E; Scheper RJ; van Ham SM; Pinedo HM; van den Eertwegh AJ
Cancer Immunol Immunother; 2006 Apr; 55(4):451-8. PubMed ID: 16034562
[TBL] [Abstract][Full Text] [Related]
3. Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine.
Euhus DM; Gupta RK; Morton DL
Cancer Immunol Immunother; 1989; 29(4):247-54. PubMed ID: 2752392
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study.
Guadagni S; Fiorentini G; Papasotiriou I; Apostolou P; Masedu F; Sarti D; Farina AR; Mackay AR; Clementi M
BMC Res Notes; 2020 Mar; 13(1):176. PubMed ID: 32204733
[TBL] [Abstract][Full Text] [Related]
5. Immune response of chimpanzee to purified melanoma 250 kilodalton tumor-associated antigen.
Stuhlmiller GM; Darrow TL; Haupt DM; Seigler HF
Cancer Immunol Immunother; 1987; 25(3):193-200. PubMed ID: 3677123
[TBL] [Abstract][Full Text] [Related]
6. Correction to: Routine imaging guided by a 31‑gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
Dhillon S; Duarte-Bateman D; Fowler G; Hagstrom MNE; Lampley N; Olivares S; Fumero-Velázquez MS; Vu K; Wayne JD; Gastman BR; Vetto J; Gerami P
Arch Dermatol Res; 2023 Oct; 315(8):2303. PubMed ID: 37043011
[No Abstract] [Full Text] [Related]
7. Correction: Routine imaging guided by a 31‑gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
Dhillon S; Duarte-Bateman D; Fowler G; Hagstrom MNE; Lampley N; Olivares S; Fumero-Velázquez MS; Vu K; Wayne JD; Gastman BR; Vetto J; Gerami P
Arch Dermatol Res; 2023 Nov; 316(1):6. PubMed ID: 38006425
[No Abstract] [Full Text] [Related]
8. Expression of autocrine motility factor receptor in cutaneous malignant melanoma.
Nagai Y; Ishikawa O; Miyachi Y; Watanabe H
Dermatology; 1996; 192(1):8-11. PubMed ID: 8832943
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of cancer incidence in Connecticut counties and towns, 1989-91.
Polednak AP; Flannery JT
Conn Med; 1995 Jun; 59(6):323-30. PubMed ID: 7648850
[TBL] [Abstract][Full Text] [Related]
10. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma.
Gause BL; Sharfman WH; Janik JE; Curti BD; Steis RG; Urba WJ; Smith JW; Alvord WG; Longo DL
Cancer Invest; 1998; 16(6):374-80. PubMed ID: 9679527
[TBL] [Abstract][Full Text] [Related]
12. In situ flat embedding of monolayers and cell relocation in the acrylic resin LR white for comparative light and electron microscopy studies.
Steiner M; Schöfer C; Mosgoeller W
Histochem J; 1994 Dec; 26(12):934-8. PubMed ID: 7896569
[TBL] [Abstract][Full Text] [Related]
13. A special surface coil for high-resolution ocular MRI.
Hosten N; Lemke AJ
Front Radiat Ther Oncol; 1997; 30():20-5. PubMed ID: 9205881
[No Abstract] [Full Text] [Related]
14. Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion.
Stern JB; Peck GL; Haupt HM; Hollingsworth HC; Beckerman T
J Am Acad Dermatol; 1993 Apr; 28(4):591-4. PubMed ID: 8463460
[TBL] [Abstract][Full Text] [Related]
15. Ocular melanoma: an experimental model in New Zealand white rabbits.
Rodriguez Vicente J; Vicente Ortega V; Garcia Serrano F; Garcia Rojo B
Melanoma Res; 1993 Jun; 3(3):195-202. PubMed ID: 8400856
[TBL] [Abstract][Full Text] [Related]
16. Further experience of public education for the early diagnosis of malignant melanoma in Leicestershire.
Healsmith MF; Graham-Brown RA; Osborne JE; London SP; Fletcher A
Clin Exp Dermatol; 1993 Sep; 18(5):396-400. PubMed ID: 8252756
[TBL] [Abstract][Full Text] [Related]
17. Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread.
Busam KJ; Barnhill RL
Am J Surg Pathol; 1995 Sep; 19(9):1061-7. PubMed ID: 7661280
[TBL] [Abstract][Full Text] [Related]
18. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A
Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980
[TBL] [Abstract][Full Text] [Related]
19. [Is involvement of the clitoris in epidermoid carcinoma of the vulva an adverse prognostic sign?].
Masák L; Hudáková G
Ceska Gynekol; 1996 Oct; 61(5):299-301. PubMed ID: 9004977
[TBL] [Abstract][Full Text] [Related]
20. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
Mihm MC; Clemente CG; Cascinelli N
Lab Invest; 1996 Jan; 74(1):43-7. PubMed ID: 8569196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]